Haleon (LON:HLN) Reaches New 52-Week Low - Time to Sell?

Key Points

• Haleon plc has hit a new 52-week low with shares trading as low as GBX 346.10 ($4.59) during mid-day trading.
• The company reported a quarterly EPS of GBX 8.90 ($0.12) and has a return on equity of 6.54% with a net margin of 9.66%.
• Insider transactions include the sale of 64,329 shares by Dawn Allen and the purchase of 21,300 shares by Marie-Anne Aymerich within the past three months.

Haleon plc (LON:HLN - Get Free Report)'s share price reached a new 52-week low on Thursday . The stock traded as low as GBX 346.10 ($4.59) and last traded at GBX 352.60 ($4.68), with a volume of 226846969 shares changing hands. The stock had previously closed at GBX 364.90 ($4.84).

Analyst Ratings Changes

A number of equities analysts recently commented on HLN shares. JPMorgan Chase & Co. reiterated an "underweight" rating on shares of Haleon in a research report on Friday. Royal Bank Of Canada reissued a "sector perform" rating and issued a GBX 370 ($4.91) price target on shares of Haleon in a report on Thursday.

Haleon Price Performance

The firm's 50 day moving average is GBX 381.70 and its 200 day moving average is GBX 385.18. The firm has a market cap of £33.02 billion, a P/E ratio of 30.77, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 53.36, a current ratio of 0.84 and a quick ratio of 0.93.

Haleon (LON:HLN - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported GBX 8.90 ($0.12) earnings per share for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. As a group, analysts anticipate that Haleon plc will post 19.5033282 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Blathnaid Bergin purchased 6,145 shares of the business's stock in a transaction on Friday, May 16th. The shares were acquired at an average price of GBX 404 ($5.36) per share, for a total transaction of £24,825.80 ($32,951.69). Also, insider Dawn Allen sold 64,329 shares of the company's stock in a transaction that occurred on Monday, June 30th. The shares were sold at an average price of GBX 376 ($4.99), for a total transaction of £241,877.04 ($321,047.31). 10.74% of the stock is currently owned by insiders.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.